Biologics in rheumatoid arthritis (RA) - recommendations for Swiss practice

被引：6

作者：

Dudler, Jean ^{[2
]}

Moeller, Burkhard ^{[1
]}

Michel, Beat A. ^{[3
]}

Villiger, Peter M. ^{[1
]}

机构：

[1] Univ Hosp Bern, Dept Rheumatol, CH-3010 Bern, Switzerland

[2] Univ Lausanne Hosp, Dept Rheumatol, Lausanne, Switzerland

[3] Univ Zurich Hosp, Dept Rheumatol, Zurich, Switzerland

来源：

SWISS MEDICAL WEEKLY | 2011年 / 141卷

关键词：

rheumatoid arthritis; biologics; anti-TNF; treatment optimisation; guidelines; CONTROLLED-TRIAL; DOUBLE-BLIND; COMBINATION THERAPY; METHOTREXATE; MULTICENTER; OUTCOMES; AGENT; ETANERCEPT; INHIBITION; RITUXIMAB;

D O I：

10.4414/smw.2011.13189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners in their daily use of those agents, to reflect the current "best practice" in Switzerland.

引用

页数：4

共 25 条

[1]

Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]

[2] Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [J].

Boers, M ;

Verhoeven, AC ;

Markusse, HM ;

vandeLaar, MAFJ ;

Westhovens, R ;

vanDenderen, JC ;

vanZeben, D ;

Dijkmans, BAC ;

Peeters, AJ ;

Jacobs, P ;

vandenBrink, HR ;

Schouten, HJA ;

vanderHeijde, DMFM ;

Boonen, A ;

vanderLinden, S .

LANCET, 1997, 350 (9074) :309-318

[3] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].

Breedveld, FC ;

Weisman, MH ;

Kavanaugh, AF ;

Cohen, SB ;

Pavelka, K ;

van Vollenhoven, R ;

Sharp, J ;

Perez, JL ;

Spencer-Green, GT .

ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37

[4] Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept [J].

Buch, Maya H. ;

Bingham, Sarah J. ;

Bejarano, Victoria ;

Bryer, Domini ;

White, Jo ;

Emery, Paul ;

Reece, Richard ;

Quinn, Mark .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (03) :448-453

[5] Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].

Cohen, Stanley B. ;

Emery, Paul ;

Greenwald, Maria W. ;

Dougados, Maxime ;

Furie, Richard A. ;

Genovese, Mark C. ;

Keystone, Edward C. ;

Loveless, James E. ;

Burmester, Gerd-Ruediger ;

Cravets, Matthew W. ;

Hessey, Eva W. ;

Shaw, Timothy ;

Totoritis, Mark C. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806

[6] IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial [J].

Emery, P. ;

Keystone, E. ;

Tony, H. P. ;

Cantagrel, A. ;

van Vollenhoven, R. ;

Sanchez, A. ;

Alecock, E. ;

Lee, J. ;

Kremer, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) :1516-1523

[7] Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? [J].

Finckh, A. ;

Ciurea, A. ;

Brulhart, L. ;

Moller, B. ;

Walker, U. A. ;

Courvoisier, D. ;

Kyburz, D. ;

Dudler, J. ;

Gabay, C. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) :387-393

[8] B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents [J].

Finckh, Axel ;

Ciurea, Adrian ;

Brulhart, Laure ;

Kyburz, Diego ;

Moeller, Burkhard ;

Dehler, Silvia ;

Revaz, Sylvie ;

Dudler, Jean ;

Gabay, Cem .

ARTHRITIS AND RHEUMATISM, 2007, 56 (05) :1417-1423

[9] Evolving concepts of rheumatoid arthritis [J].

Firestein, GS .

NATURE, 2003, 423 (6937) :356-361

[10] Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition [J].

Genovese, MC ;

Becker, J ;

Schiff, M ;

Luggen, M ;

Sherrer, Y ;

Kremer, J ;

Birbara, C ;

Box, J ;

Natarajan, K ;

Nuamah, I ;

Li, T ;

Aranda, R ;

Hagerty, DT ;

Dougados, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (11) :1114-1123

← 1 2 3 →